World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
41422
World Ranking
9160
National Ranking
4725

Overview

Daniel P. Judge is affiliated with the Medical University of South Carolina in the United States. Their research spans multiple areas within medicine, biochemistry, genetics, and molecular biology. The primary fields of study include Medicine and Biochemistry, Genetics and Molecular Biology, with notable focus on subfields such as Cardiology and Cardiovascular Medicine, Molecular Biology, Genetics, Nephrology, and Surgery.

Research topics frequently addressed by Daniel P. Judge involve:

  • Cardiomyopathy and Myosin Studies
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Cardiovascular Effects of Exercise
  • Parathyroid Disorders and Treatments
  • Cardiovascular Function and Risk Factors
  • Genomics and Rare Diseases
  • Viral Infections and Immunology Research

Their publication record includes contributions to several prominent journals. The most common venues for their work are:

  • Journal of the American College of Cardiology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Circulation
  • Circulation Genomic and Precision Medicine
  • Journal of Cardiac Failure

Daniel P. Judge's recent papers cover diverse aspects of cardiology and molecular medicine, including:

  • "Evidence-Based Assessment of Genes in Dilated Cardiomyopathy," 2021, Circulation
  • "Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy," 2024, New England Journal of Medicine
  • "Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis," 2020, JACC Heart Failure
  • "Epidemiology of the inherited cardiomyopathies," 2020, Nature Reviews Cardiology
  • "International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework," 2021, Circulation Genomic and Precision Medicine

Their frequent coauthors include:

  • Douglas Stoller
  • Ray E. Hershberger
  • Cynthia A. James
  • Elizabeth T. Cirulli
  • Elizabeth Jordan

Best Publications

  • Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

    Mathew S. Maurer;Jeffrey H. Schwartz;Balarama Gundapaneni;Perry M. Elliott

  • HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)

    Michael J. Ackerman;Silvia G. Priori;Stephan Willems;Charles Berul

  • Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.

    Jennifer P. Habashi;Daniel P. Judge;Tammy M. Holm;Ronald D. Cohn

  • A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2

    Bart L Loeys;Junji Chen;Enid R Neptune;Daniel P Judge

  • Marfan’s syndrome

    Daniel P Judge;Harry C Dietz

  • HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies

    Michael J. Ackerman;Silvia G. Priori;Stephan Willems;Charles Berul

  • Angiotensin II Blockade and Aortic-Root Dilation in Marfan's Syndrome

    Benjamin S. Brooke;Jennifer P. Habashi;Daniel P. Judge;Nishant Patel

  • Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states

    Ronald D Cohn;Christel van Erp;Jennifer P Habashi;Arshia A Soleimani

  • 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy

    Jeffrey A. Towbin;William J. McKenna;Dominic J. Abrams;Michael J. Ackerman

  • Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers

    Cynthia A. James;Aditya Bhonsale;Crystal Tichnell;Brittney Murray

  • Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline

    Ray E. Hershberger;Michael M. Givertz;Carolyn Y. Ho;Daniel P. Judge

  • TGF-β–dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome

    Connie M. Ng;Alan Cheng;Loretha A. Myers;Francisco Martinez-Murillo

  • Arrhythmogenic Right Ventricular Dysplasia A United States Experience

    Darshan Dalal;Khurram Nasir;Chandra Bomma;Kalpana Prakasa

  • Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK Antagonism

    Jennifer P. Habashi;Jefferson J. Doyle;Tammy M. Holm;Hamza Aziz

  • Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs

    Changsung Kim;Johnson Wong;Jianyan Wen;Shirong Wang

  • Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome

    Daniel P. Judge;Nancy J. Biery;Douglas R. Keene;Jessica Geubtner

  • Noncanonical TGFβ Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome Mice

    Tammy M. Holm;Jennifer P. Habashi;Jefferson J. Doyle;Djahida Bedja

  • Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: Evidence supporting the concept of arrhythmogenic cardiomyopathy

    Paul A. van der Zwaag;Ingrid A. W. van Rijsingen;Angeliki Asimaki;Jan D. H. Jongbloed

  • The molecular genetics of Marfan syndrome and related disorders

    Peter N. Robinson;E. Arteaga-Solis;C. Baldock;G. Collod-Béroud

  • Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).

    Mathew S. Maurer;Mazen Hanna;Martha Grogan;Angela Dispenzieri

Frequent Co-Authors

Hugh Calkins
Hugh Calkins Johns Hopkins University
Stuart D. Russell
Stuart D. Russell Duke University
Harry C. Dietz
Harry C. Dietz Johns Hopkins University School of Medicine
Arthur A.M. Wilde
Arthur A.M. Wilde University of Amsterdam
David A. Bluemke
David A. Bluemke University of Wisconsin–Madison
Dennis Dooijes
Dennis Dooijes Utrecht University
Mathew S. Maurer
Mathew S. Maurer Columbia University
David A. Kass
David A. Kass Johns Hopkins University School of Medicine
Jeffrey E. Saffitz
Jeffrey E. Saffitz Beth Israel Deaconess Medical Center
Bart Loeys
Bart Loeys University of Antwerp

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The medical field in the USA offers a variety of online degree options and pathways for those seeking flexibility or alternative routes into healthcare. For students interested in the business side of medicine, online medical billing and coding with financial aid programs make it possible to enter the workforce quickly while managing costs.

For those with prior degrees or experience, some absn programs that don't require teas exams enable faster entry to nursing careers and eliminate standardized test barriers. If you aspire to leadership or administrative roles, a healthcare administration online degree can provide the flexibility to balance study, life, and work.

Current registered nurses can leverage rn to np programs online to bridge their education and advance into nurse practitioner roles. Each of these programs supports a different medical career path, helping you find the right fit for your goals, schedule, and budget.

Best Scientists Citing Daniel P. Judge

Trending Scientists

Recently Published Articles